Target intelligence / Profile preview

Ribosomal protein L26 pseudogene 30 (RPL26P30)

Target
RPL26P30
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L26 pseudogene 30 (RPL26P30) is a processed pseudogene related to the ribosomal protein L26 gene, which normally encodes a structural component of the 60S large ribosomal subunit[2]. Pseudogenes like RPL26P30 do not produce functional proteins, and this gene does not encode a functional receptor, enzyme, or other therapeutic target. It is one of multiple dispersed pseudogenes found within the genome that arose from duplication or retrotransposition of the parent ribosomal protein gene[2]. There is no evidence for therapeutic targeting, disease association, or regulatory function reported for this pseudogene. RPL26P30 is not a coding gene nor a biological target, but a non-functional genomic sequence related to the ribosome[2]. Its parent gene, RPL26, encodes a protein that is a component of ribosomal subunit 60S, with an established role in protein synthesis[1][3]. Pseudogenes are not typically involved in disease, drug targeting, or biological functions unless specifically proven otherwise, which is not the case for RPL26P30.

Other names
RPL26_10_1113RPL26P30

Beyond the preview

Go deeper on Ribosomal protein L26 pseudogene 30 (RPL26P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L26 pseudogene 30 (RPL26P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call